PBSV · Pharma-Bio Serv, Inc. · Analyst Estimates
4 customers — 55.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
4 customers — 53.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
4 customers — 52.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
4 customers — 49.1% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 23.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 23.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 22.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 18.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 18.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 18.3% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 17.9% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 14.7% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 13.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 13.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 6.4% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 6.4% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 5.5% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 5.5% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 0.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 0.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
4 customers — 44.5% of receivables (July 31, 2026)
“On July 31, 2026, amounts due from these customers represented 44.5% of the Company's total accounts receivable balance.”
Analyst Estimates
Compare analyst forecasts for Pharma-Bio Serv, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 21:29 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-10-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.04
|
0.04
|
0.04
|
1
|
0.07
|
0.07
|
0.07
|
0.07
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
11.00M
|
11.00M
|
11.00M
|
1
|
— | — | — | — | — | — | — | — |
FY ending 2027-10-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.11
|
0.11
|
0.11
|
1
|
0.11
|
0.11
|
0.11
|
0.11
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
12.90M
|
12.90M
|
12.90M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-10-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.03
|
0.03
|
0.03
|
1
|
0.03
|
0.03
|
0.03
|
0.03
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
2.70M
|
2.70M
|
2.70M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2027-01-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.02
|
0.02
|
0.02
|
1
|
0.02
|
0.02
|
0.02
|
0.02
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
2.60M
|
2.60M
|
2.60M
|
1
|
— | — | — | — | — | — | — | — |